CircPrimer 2.0: a software for annotating circRNAs and predicting translation potential of circRNAs von Zhong, Shanliang, Feng, Jifeng

Volltext

Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures von Feng, Bing, Wu, Jianzhong, Shen, Bo, Jiang, Feng, Feng, Jifeng

Volltext

CircPrimer: a software for annotating circRNAs and determining the specificity of circRNA primers von Zhong, Shanliang, Wang, Jinyan, Zhang, Qian, Xu, Hanzi, Feng, Jifeng

Volltext

LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3 von Zhao, Xia, Li, Xiaoyou, Zhou, Leilei, Ni, Jie, Yan, Wenyue, Ma, Rong, Wu, Jianzhong, Feng, Jifeng, Chen, Ping

Volltext

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial von Wang, Zi-Xian, Cui, Chengxu, Yao, Jun, Zhang, Yanqiao, Li, Mengxia, Feng, Jifeng, Yang, Shujun, Fan, Yun, Shi, Jianhua, Zhang, Xizhi, Shen, Lin, Shu, Yongqian, Wang, Cailian, Dai, Tianyang, Mao, Teng, Chen, Long, Guo, Zengqing, Liu, Bo, Pan, Hongming, Cang, Shundong, Jiang, Yi, Wang, Junye, Ye, Min, Chen, Zhendong, Jiang, Da, Lin, Qin, Ren, Wei, Wang, Junsheng, Wu, Lin, Xu, Yong, Miao, Zhanhui, Sun, Meili, Xie, Conghua, Liu, Ying, Wang, Qifeng, Zhao, Lina, Li, Qi, Huang, Canhong, Jiang, Ke, Yang, Kunyu, Li, Daojun, Liu, Yunpeng, Zhu, Zhitu, Chen, Rixin, Jia, Liqun, Li, Wei, Liao, Wangjun, Liu, Hong-Xu, Ma, Daiyuan, Ma, Jie, Qin, Yanru, Shi, Zhihong, Wei, Qichun, Xiao, Ke, Zhang, Yan, Zhang, Ying, Chen, Xin, Dai, Guanghai, He, Jianxing, Li, Junhe, Li, Guanghui, Liu, Yong, Liu, Zhihua, Yuan, Xianglin, Zhang, Junping, Fu, Zhichao, He, Yifu, Ju, Fang, Liu, Zheng, Tang, Peng, Wang, Tiejun, Wang, Weibo, Zhang, Jing, Luo, Xianming, Tang, Xiongwen, May, Rena, Feng, Hui, Yao, Sheng, Keegan, Patricia, Xu, Rui-Hua, Wang, Feng

Volltext

C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis von Zhu, Meng, Ma, Zhimin, Zhang, Xu, Hang, Dong, Yin, Rong, Feng, Jifeng, Xu, Lin, Shen, Hongbing

Volltext

Clinical significance of preoperative CALLY index for prognostication in patients with esophageal squamous cell carcinoma undergoing surgery von Feng, Jifeng, Wang, Liang, Yang, Xun, Chen, Qixun

Volltext

LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1 von Li, Chenchen, Zhao, Wei, Pan, Xuan, Li, Xiaoyou, Yan, Fei, Liu, Siwen, Feng, Jifeng, Lu, Jianwei

Volltext

The role of LncRNAs in tumor immunotherapy von Pan, Xuan, Li, Chenchen, Feng, Jifeng

Volltext

LncRNA SNHG15: A new budding star in human cancers von Shuai, You, Ma, Zhonghua, Lu, Jianwei, Feng, Jifeng

Volltext

A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9) von Lv, Yan, Ma, Xiao, Ma, Yuxin, Du, Yuxin, Feng, Jifeng

Volltext

EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells von Yu, Shaorong, Sha, Huanhuan, Qin, Xiaobing, Chen, Yan, Li, Xiaoyou, Shi, Meiqi, Feng, Jifeng

Volltext

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label... von Wu, Yi-Long, Prof, Zhou, Caicun, Prof, Hu, Cheng-Ping, Prof, Feng, Jifeng, Prof, Lu, Shun, Prof, Huang, Yunchao, Prof, Li, Wei, Prof, Hou, Mei, Prof, Shi, Jian Hua, Prof, Lee, Kye Young, Prof, Xu, Chong-Rui, MD, Massey, Dan, MSc, Kim, Miyoung, MD, Shi, Yang, MD, Geater, Sarayut L, MD

Volltext

Preoperative inflammatory burden index for prognostication in esophageal squamous cell carcinoma undergoing radical resection von Zhao, Qiang, Wang, Liang, Yang, Xun, Feng, Jifeng, Chen, Qixun

Volltext

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple‐negative breast cancer von Hu, Xichun, Zhang, Jian, Xu, Binghe, Jiang, Zefei, Ragaz, Joseph, Tong, Zhongsheng, Zhang, Qingyuan, Wang, Xiaojia, Feng, Jifeng, Pang, Danmei, Fan, Minhao, Li, Jin, Wang, Biyun, Wang, Zhonghua, Zhang, Qunling, Sun, Si, Liao, Chunmei

Volltext

LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1 von Huang, Jiayuan, Pan, Banzhou, Xia, Guohao, Zhu, Jingni, Li, Chenchen, Feng, Jifeng

Volltext

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label,... von Zhou, Caicun, Prof, Wu, Yi-Long, Prof, Chen, Gongyan, Prof, Feng, Jifeng, Prof, Liu, Xiao-Qing, Prof, Wang, Changli, Prof, Zhang, Shucai, Prof, Wang, Jie, Prof, Zhou, Songwen, MD, Ren, Shengxiang, MD, Lu, Shun, Prof, Zhang, Li, Prof, Hu, Chengping, Prof, Hu, Chunhong, Prof, Luo, Yi, Prof, Chen, Lei, Prof, Ye, Ming, Prof, Huang, Jianan, Prof, Zhi, Xiuyi, Prof, Zhang, Yiping, Prof, Xiu, Qingyu, Prof, Ma, Jun, Prof, You, Changxuan, Prof

Volltext

Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant immunochemotherapy von Zhao, Qiang, Wang, Liang, Yang, Xun, Feng, Jifeng, Chen, Qixun

Volltext

CircMERTK modulates the suppressive capacity of tumor-associated macrophage via targeting IL-10 in colorectal cancer von Zhu, Mingchen, Zhu, Zining, Jiang, Pan, Zheng, Junyu, Yan, Feng, Feng, Jifeng

Volltext

A Three-Genes Signature Predicting Colorectal Cancer Relapse Reveals LEMD1 Promoting CRC Cells Migration by RhoA/ROCK1 Signaling Pathway von Zhang, Hui, Xu, Chenxin, Jiang, Feng, Feng, Jifeng

Volltext